SPX4,065.97-10.60 -0.26%
DIA344.35-0.06 -0.02%
IXIC11,444.03-38.42 -0.33%

--Citigroup Adjusts Price Target on Clover Health Investments to $1.80 From $3.50, Maintains Neutral Rating

--Citigroup Adjusts Price Target on Clover Health Investments to $1.80 From $3.50, Maintains Neutral Rating

MT Newswires · 11/16/2022 05:24

Please log in to view news